Matinas BioPharma Holdings, Inc.

Learn More About Cochleate Technology

Matinas BioPharma’s mission is to transform the way potent medicines are delivered and administered.

Learn More About Our Science

Super Bugs Video

About Matinas Biopharma

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. The Company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable.

about matinas biopharma »

Drug Pipeline

Candidate & Indication Development Stage
IND Preparation Phase 1 Development Phase 2 Development Phase 3 Development Market
MAT2203 Prevention of IFI in Acute Lymphoblastic Leukemia
IND Preparation Phase complete
Phase 1 Development Phase complete
Phase 2 Development Phase in progress
Phase 3 Development Phase not started
Market Phase not started
MAT2501 Non-Tuberculous Mycobacterium (NTM) Infections
IND Preparation Phase complete
Phase 1 Development Phase in progress
Phase 2 Development Phase not started
Phase 3 Development Phase not started
Market Phase not started